成人免费xx,国产又黄又湿又刺激不卡网站,成人性视频app菠萝网站,色天天天天

Home Cart 0 Sign in  

[ CAS No. 4009-98-7 ] {[proInfo.proName]}

,{[proInfo.pro_purity]}
Cat. No.: {[proInfo.prAm]}
Chemical Structure| 4009-98-7
Chemical Structure| 4009-98-7
Structure of 4009-98-7 * Storage: {[proInfo.prStorage]}

Please Login or Create an Account to: See VIP prices and availability

Cart0 Add to My Favorites Add to My Favorites Bulk Inquiry Inquiry Add To Cart

Search after Editing

* Storage: {[proInfo.prStorage]}

* Shipping: {[proInfo.prShipping]}

Quality Control of [ 4009-98-7 ]

Related Doc. of [ 4009-98-7 ]

Alternatived Products of [ 4009-98-7 ]
Product Citations

Product Details of [ 4009-98-7 ]

CAS No. :4009-98-7 MDL No. :MFCD00011800
Formula : C20H20ClOP Boiling Point : -
Linear Structure Formula :[(C6H5)3PCH2OCH3]Cl InChI Key :SJFNDMHZXCUXSA-UHFFFAOYSA-M
M.W : 342.80 Pubchem ID :2723798
Synonyms :

Calculated chemistry of [ 4009-98-7 ]      Expand+

Physicochemical Properties

Num. heavy atoms : 23
Num. arom. heavy atoms : 18
Fraction Csp3 : 0.1
Num. rotatable bonds : 5
Num. H-bond acceptors : 1.0
Num. H-bond donors : 0.0
Molar Refractivity : 102.76
TPSA : 22.82 ?2

Pharmacokinetics

GI absorption : High
BBB permeant : No
P-gp substrate : Yes
CYP1A2 inhibitor : No
CYP2C19 inhibitor : No
CYP2C9 inhibitor : No
CYP2D6 inhibitor : Yes
CYP3A4 inhibitor : No
Log Kp (skin permeation) : -4.58 cm/s

Lipophilicity

Log Po/w (iLOGP) : -1.17
Log Po/w (XLOGP3) : 5.37
Log Po/w (WLOGP) : 0.59
Log Po/w (MLOGP) : 4.78
Log Po/w (SILICOS-IT) : 4.62
Consensus Log Po/w : 2.84

Druglikeness

Lipinski : 1.0
Ghose : None
Veber : 0.0
Egan : 0.0
Muegge : 1.0
Bioavailability Score : 0.55

Water Solubility

Log S (ESOL) : -5.6
Solubility : 0.000866 mg/ml ; 0.00000253 mol/l
Class : Moderately soluble
Log S (Ali) : -5.6
Solubility : 0.000855 mg/ml ; 0.0000025 mol/l
Class : Moderately soluble
Log S (SILICOS-IT) : -8.06
Solubility : 0.00000297 mg/ml ; 0.0000000086 mol/l
Class : Poorly soluble

Medicinal Chemistry

PAINS : 0.0 alert
Brenk : 1.0 alert
Leadlikeness : 1.0
Synthetic accessibility : 4.48

Safety of [ 4009-98-7 ]

Signal Word:Warning Class:N/A
Precautionary Statements:P501-P270-P264-P280-P337+P313-P301+P312+P330 UN#:N/A
Hazard Statements:H302-H315-H319 Packing Group:N/A
GHS Pictogram:

Application In Synthesis of [ 4009-98-7 ]

* All experimental methods are cited from the reference, please refer to the original source for details. We do not guarantee the accuracy of the content in the reference.

  • Downstream synthetic route of [ 4009-98-7 ]

[ 4009-98-7 ] Synthesis Path-Downstream   1~4

  • 1
  • [ 4009-98-7 ]
  • 2-[4-[(E)-2-methoxyethenyl]phenyl]-pyrazine [ No CAS ]
  • [ 127406-08-0 ]
YieldReaction ConditionsOperation in experiment
820 mg (71%) With sodium hexamethyldisilazane; In tetrahydrofuran; Step A 2-[4-[(E)-2-methoxyethenyl]phenyl]-pyrazine Sodium hexamethyldisilazide (10.80 mL, 10.80 mmol, 11.0M in THF) was added to a suspension of methoxymethyltriphenylphosphonium chloride (3.72 g, 10.80 mmol) in THF (20 mL) at -10 C., and the red-orange mixture was stirred for 15 min at -10 C. A solution of 4-pyrazinylbenzaldehyde (1.00 g, 5.43 mmol) prepared as described in reference example 17) in THF (3 mL) was added dropwise, and stirring was continued at -10 C. for 1 h. The reaction mixture was quenched with sat. aq. NH4Cl, extracted with ethyl acetate, the organic layer dried with Na2SO4, and concentrated in vacuo. Purification by medium pressure liquid chromatography (SiO2, 3:1 hexane/ethyl acetate) yielded 820 mg (71%) of the title compound (E:Z=1:1). MS 213 (M+H)+.
  • 2
  • [ 4363-94-4 ]
  • [ 4009-98-7 ]
  • C13H13NO2 [ No CAS ]
  • 3
  • [ 56309-94-5 ]
  • [ 4009-98-7 ]
  • 8-(4-(methoxymethylene)cyclohexyl)-1,4-dioxaspiro[4.5]decane [ No CAS ]
YieldReaction ConditionsOperation in experiment
76% To a stirring solution of (methoxymethyl)triphenylphosphonium chloride (3.74 g, 10.91 mmol) in THF (16 mL) was added potassium tert-butoxide (1.224 g, 10.91 mmol) portionwise. The solution was stirred at room temperature for 50 min then a solution of <strong>[56309-94-5]4-(1,4-dioxaspiro[4.5]decan-8-yl)cyclohexanone</strong> (2 g, 8.39 mmol) in THF (16 mL) was added slowly. The reaction mixture was stirred for 3.5 h. The solvent was removed under vacuum. The residue was treated with Et2O (44 mL) and stirred for 1 h. The mixture was filtered, washed with Et2O (2 x 50 mL) and the filtrate was evaporated. The crude product was purified by column chromatography (EA/Iso- hexane) to afford 1.8 g (76percent) of 8-(4-(methoxymethylene)cyclohexyl)-l ,4- dioxaspiro[4.5]decane as a colourless oil.
  • 4
  • [ 1181816-12-5 ]
  • [ 4009-98-7 ]
  • tert-butyl 6-(methoxymethylene)-2-azaspiro[3.3]heptane-2-carboxylate [ No CAS ]
YieldReaction ConditionsOperation in experiment
To a solution of (methoxymethyl)triphenylphosphonium chloride (2.92 g, 8.52 mmol) in THF (20 mL) was added dropwise LDA (4.47 ml, 8.95 mmol, 1.0 M in THF) over 20 mm under N2 at 0 °C. The reaction mixture was stirred at room temperature for 2 h. Then a solution of tertbutyl 6-oxo-2-azaspiro[3.3jheptane-2-carboxylate (900 mg, 4.26 mmol) in THF (10 mL) was added dropwise to the mixture. The reaction mixture was stirred at 60 °C for 3 h, thenquenched with water (30 mL) and extracted with ethyl acetate (20 mL x 3). The combined organic layers were washed with water (40 mL) and brine (40 mL), dried over anhydrous MgSO4 and filtered. The filtrate was concentrated under reduced pressure. The resulting residue was purified by column chromatography on silica gel eluted with PE / EtOAc (50:1- 20: 1, v/v) to give the title compound. ?H NMR (400 MI-Tz, CDC13): oe = 5.81 (s, 1H), 3.93(s, 4H), 3.56 (s, 3H), 2.87 (s, 2H), 2.79 (s, 2H), 1.44 (s, 12H).
Recommend Products
Same Skeleton Products

Technical Information

Historical Records
; ;